… From 2015 onwards, reversibility was routinely tested in response to 2.5 mg nebulised
salbutamol. A positive response was defined as an increase in FEV 1 of at least 12% and 200 mL. …

… reversibility testing classifies the airway obstruction as reversible or irreversible and thereby
guides therapeutic … responded to the bronchodilator reversibility test in our sample and the …

… Table 1: Mean measured values (3 sf) for pre- and post-salbutamol for all four lung function
tests for both MDI (and spacer) and nebuliser, along with their respective change scores and …

… (5%) combined with salbutamol in the nebulizer cup. Sputum was then processed using the
… ), whereas those combining both positive reversibility test and positive bronchial challenge …

… of delivery by a nebulizer in patients with chronic … testing are rare. This study assessed the
effects of salbutamol administered by an MDI with spacer versus a nebulizer on BDR testing of …

… Reversibility of bronchoconstriction after inhalation of the drug can be used as an indicator
… One way analysis of variance (ANOVA) test was used to compare the results with the least …

… a sidestream jet nebulizer with a mouthpiece. … nebulizer [25]. Albuterol (400 μg) delivered
via MDI with a valved holding chamber (VHC) is a standard method for bronchodilator testing …

… reversibility test and received nebulizer or HandiHaler ® (Spiriva ® HandiHaler; Boehringer
Ingelheim, Ridgefield, CT, USA) training as appropriate. At the following clinic visit (day 1 of …

… nebulizer groups was performed using unpaired t test, Wilcoxon rank-sum test, or chi-square
test … 200 mL in accordance with ATS reversibility criteria. Volume response incorporated the …

… with reversible airflow … test lab for randomisation within 1–3 days of initial screening to
inhale saline and an escalating dose of albuterol administered by vibrating mesh nebuliser (VMN, …